Neurocrine Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Hello, everyone, and welcome to Oppenheimer's 31st Annual Healthcare Conference. I'm Jay Olson, one of the biotech analysts at Oppenheimer, and I want to thank you all for joining us.
It's my pleasure to welcome Neurocrine Biosciences to our conference, and it's an honor to introduce Matt Abernethy, the CFO; and Eiry Roberts, the CMO.
And with that, let's get started. Maybe if there are any opening remarks, you'd like to share with us before we get started, Matt or Eiry?
Yes, sure, Jay. Good to see you. Good to see you in your office in New York. It's satisfying given a year out. Eiry and I are both in the offices as well. And actually, both fully vaccinated at this point. So happy to say that.
Before we begin, we will be making forward-looking statements, so we direct you to our SEC filings for the related risk factors and uncertainties associated with our company and then also
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
